Overview | Product information | Accredo services | Contact team
Actimmune is indicated for reducing the frequency and severity of serious infections associated with chronic granulomatous disease (CGD) and for delaying time to disease progression in patients with severe, malignant osteopetrosis.
For more information, please visit Actimmune.com, or download the full prescribing information.
Actimmune is a registered trademark of InterMune, Inc.
